These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 26276724)
1. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Fernández L; Valentín J; Zalacain M; Leung W; Patiño-García A; Pérez-Martínez A Cancer Lett; 2015 Nov; 368(1):54-63. PubMed ID: 26276724 [TBL] [Abstract][Full Text] [Related]
2. Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells. Fernández L; Metais JY; Escudero A; Vela M; Valentín J; Vallcorba I; Leivas A; Torres J; Valeri A; Patiño-García A; Martínez J; Leung W; Pérez-Martínez A Clin Cancer Res; 2017 Oct; 23(19):5824-5835. PubMed ID: 28659311 [No Abstract] [Full Text] [Related]
3. Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells Wang Z; Wang Z; Li S; Li B; Sun L; Li H; Lin P; Wang S; Teng W; Zhou X; Ye Z Front Immunol; 2018; 9():1239. PubMed ID: 29910819 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells. Buddingh EP; Schilham MW; Ruslan SE; Berghuis D; Szuhai K; Suurmond J; Taminiau AH; Gelderblom H; Egeler RM; Serra M; Hogendoorn PC; Lankester AC Cancer Immunol Immunother; 2011 Apr; 60(4):575-86. PubMed ID: 21240486 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma. Rainusso N; Brawley VS; Ghazi A; Hicks MJ; Gottschalk S; Rosen JM; Ahmed N Cancer Gene Ther; 2012 Mar; 19(3):212-7. PubMed ID: 22173710 [TBL] [Abstract][Full Text] [Related]
6. Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis. Guma SR; Lee DA; Yu L; Gordon N; Hughes D; Stewart J; Wang WL; Kleinerman ES Pediatr Blood Cancer; 2014 Apr; 61(4):618-26. PubMed ID: 24136885 [TBL] [Abstract][Full Text] [Related]
7. Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity. Yamanegi K; Yamane J; Kobayashi K; Kato-Kogoe N; Ohyama H; Nakasho K; Yamada N; Hata M; Nishioka T; Fukunaga S; Futani H; Okamura H; Terada N Oncol Rep; 2010 Dec; 24(6):1621-7. PubMed ID: 21042760 [TBL] [Abstract][Full Text] [Related]
8. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Verhoeven DH; de Hooge AS; Mooiman EC; Santos SJ; ten Dam MM; Gelderblom H; Melief CJ; Hogendoorn PC; Egeler RM; van Tol MJ; Schilham MW; Lankester AC Mol Immunol; 2008 Sep; 45(15):3917-25. PubMed ID: 18657862 [TBL] [Abstract][Full Text] [Related]
15. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492 [TBL] [Abstract][Full Text] [Related]
16. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma. Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361 [TBL] [Abstract][Full Text] [Related]
18. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner. Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985 [TBL] [Abstract][Full Text] [Related]
20. Natural killer group 2D receptor and its ligands in cancer immune escape. Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]